Download - WHOCC

Combinations of two or more antibacterials for systemic use and other substances
are classified in this group, e.g. antibacterials and corticosteroids.
QJ01X
OTHER ANTIBACTERIALS
Antibacterials with various modes of action not classified in the preceding groups
are assigned to this group.
QJ01XA
Glycopeptide antibacterials
Glycopeptide antibacterials, which inhibit the cell wall synthesis of Gram-positive
bacteria, are classified in this group.
Vancomycin e.g. is classified in this group. However, oral formulations containing
vancomycin are classified in QA07A - Intestinal antiinfectives.
QJ01XB
Polymyxins
Polymyxin antibacterials acting on the bacterial cytoplasm membrane are classified
in this group.
Oral products containing colistin are classified in QA07 - Antidiarrheals, intestinal
antiinflammatory/antiinfective agents.
QJ01XC
Steroid antibacterials
Steroid antibacterials, which inhibit the binding of bacterial transfer-RNA and the
50-S part of the ribosomes, are classified in this group.
QJ01XD
Imidazole derivatives
Imidazole antibacterials acting through active metabolites in anaerobic bacteria
should be classified in this group.
Only formulations for parenteral use of e.g. metronidazole are classified in this
group.
Oral formulations of imidazole derivatives are classified in QP51 - Antiprotozoals,
and formulations for gynecological/urinary use are classified in QG01 -
Gynecological antiinfectives and antiseptics and QG51 - Antiinfectives and
antiseptics for intrauterine use.
QJ01XE
QJ01XQ
Nitrofuran derivatives
Pleuromutilins
This group does not appear in the ATC human system.
121